PBH: Prestige Consumer Healthcare Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 3,258.48
Enterprise Value ($M) 4,337.81
Book Value ($M) 1,655.08
Book Value / Share 33.16
Price / Book 1.97
NCAV ($M) -1,288.29
NCAV / Share -25.81
Price / NCAV -2.53

Profitability (mra)
Return on Invested Capital (ROIC) 0.07
Return on Assets (ROA) 0.06
Return on Equity (ROE) 0.14

Liquidity (mrq)
Quick Ratio 2.02
Current Ratio 3.20

Balance Sheet (mrq) ($M)
Current Assets 375.04
Assets 3,318.42
Liabilities 1,663.33
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 1,125.36
Operating Income 342.43
Net Income 209.34
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 248.93
Cash from Investing -20.11
Cash from Financing -241.01

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G Macquarie Group Ltd 6.17
02-14 13G Ariel Investments, Llc
02-13 13G/A Vanguard Group Inc 11.60 0.13
02-09 13G/A Dimensional Fund Advisors Lp 6.90 -6.54
01-19 13G/A BlackRock Inc. 18.30 -3.61

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-15 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-02-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-11-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-06-21 45,437 372,923 12.18
2024-06-20 47,905 184,791 25.92
2024-06-18 31,683 130,859 24.21
2024-06-17 26,395 150,474 17.54

(click for more detail)

Similar Companies
MRK – Merck & Co., Inc. NUVB – Nuvation Bio Inc.
OGN – Organon & Co. PFE – Pfizer Inc.
PRGO – Perrigo Company plc


Financial data and stock pages provided by
Fintel.io